Saturday, September 5, 2026
Home Authors Posts by Ogkologos

Ogkologos

4329 POSTS 0 COMMENTS

Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab

Ogkologos -
0

Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive...

Ogkologos -
0

FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced...

Ogkologos -
0

Treating the Whole Person: How Cancer Centers Are Addressing Social Needs

Ogkologos -
0

One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with...

Ogkologos -
0

PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients...

Ogkologos -
0

FDA Grants Accelerated Approval to Adagrasib with Cetuximab for KRAS G12C-mutated...

Ogkologos -
0

Second- or Third-Line Treatment with Tisotumab Vedotin Results in Greater Efficacy...

Ogkologos -
0
1...697071...433Page 70 of 433

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com